Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut

NCT01275508 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: FITC-Adalimumab

Sponsor

University of Erlangen-Nürnberg Medical School

Collaborators

[object Object]